Viiv Healthcare
Clinical trials sponsored by Viiv Healthcare, explained in plain language.
-
HIV patients to continue promising treatment in new study
Disease control Not yet recruitingThis study offers ongoing access to HIV treatment for people who completed a previous ViiV Healthcare study and are still benefiting from it. It includes 183 participants and focuses on safety monitoring. The goal is to provide continuous care until other options are available.
Phase: PHASE3 • Sponsor: ViiV Healthcare • Aim: Disease control
Last updated May 07, 2026 18:42 UTC
-
New HIV drug candidate enters first human safety tests
Disease control Not yet recruitingThis early-stage study tests a new experimental HIV drug called VH4770359 in 214 healthy adults. The main goal is to check if the drug is safe and how the body processes it. Results will help design future studies in people living with HIV.
Phase: PHASE1 • Sponsor: ViiV Healthcare • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
New hope: HIV prevention drug studied in newborns
Prevention Not yet recruitingThis study tests the safety and how the body handles cabotegravir, an HIV prevention medicine, in newborns (up to 10 days old) who were exposed to HIV-1. About 66 healthy babies weighing at least 2 kg will receive the drug either by mouth or injection. The goal is to find safe do…
Phase: PHASE1, PHASE2 • Sponsor: ViiV Healthcare • Aim: Prevention
Last updated May 12, 2026 13:41 UTC